Susquehanna Fundamental Investments LLC Buys Shares of 14,304 Huron Consulting Group Inc. (NASDAQ:HURN)

Susquehanna Fundamental Investments LLC acquired a new stake in Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 14,304 shares of the business services provider's stock, valued at approximately $1,777,000. Susquehanna Fundamental Investments LLC owned 0.08% of Huron Consulting Group as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Two Sigma Securities LLC purchased a new position in Huron Consulting Group during the fourth quarter valued at approximately $209,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Huron Consulting Group by 3.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 19,264 shares of the business services provider's stock valued at $2,394,000 after purchasing an additional 596 shares in the last quarter. Tower Research Capital LLC TRC lifted its stake in shares of Huron Consulting Group by 27.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock valued at $71,000 after purchasing an additional 122 shares during the period. Teachers Retirement System of The State of Kentucky boosted its holdings in Huron Consulting Group by 19.6% during the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 14,296 shares of the business services provider's stock worth $1,776,000 after buying an additional 2,342 shares in the last quarter. Finally, MetLife Investment Management LLC grew its position in Huron Consulting Group by 6.9% during the fourth quarter. MetLife Investment Management LLC now owns 10,617 shares of the business services provider's stock valued at $1,319,000 after buying an additional 682 shares during the period. Institutional investors and hedge funds own 93.90% of the company's stock.

Huron Consulting Group Price Performance

NASDAQ:HURN traded up $6.44 during trading hours on Friday, hitting $147.36. 341,310 shares of the stock were exchanged, compared to its average volume of 147,810. The firm's fifty day moving average price is $143.09 and its 200 day moving average price is $129.80. Huron Consulting Group Inc. has a 52-week low of $84.87 and a 52-week high of $153.85. The company has a market cap of $2.64 billion, a P/E ratio of 32.03 and a beta of 0.37. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The business services provider reported $1.68 EPS for the quarter, beating the consensus estimate of $1.16 by $0.52. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The firm had revenue of $404.14 million during the quarter, compared to the consensus estimate of $389.27 million. During the same period in the prior year, the company earned $1.23 EPS. The firm's revenue was up 11.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Huron Consulting Group Inc. will post 6.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on HURN. Benchmark reiterated a "buy" rating and issued a $165.00 price objective on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Wedbush increased their price target on Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research report on Wednesday, March 26th. William Blair reissued an "outperform" rating on shares of Huron Consulting Group in a report on Wednesday, March 26th. Truist Financial upped their target price on Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. Finally, Barrington Research reissued an "outperform" rating and issued a $167.00 price target on shares of Huron Consulting Group in a research note on Thursday, March 27th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $169.25.

Insider Buying and Selling

In related news, Director John Mccartney sold 500 shares of the company's stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $142.67, for a total value of $71,335.00. Following the transaction, the director now directly owns 52,121 shares in the company, valued at approximately $7,436,103.07. This represents a 0.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director James H. Roth sold 2,000 shares of the firm's stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $126.03, for a total value of $252,060.00. Following the sale, the director now directly owns 48,534 shares of the company's stock, valued at approximately $6,116,740.02. This trade represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 78,781 shares of company stock worth $11,484,452. 2.15% of the stock is owned by insiders.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.